Healthcare provider profile · identity verified

Edward M Schellinck, MD

General Practice · TURLOCK, CA · NPI 1487614137

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	485	145
Atorvastatin Calcium	Atorvastatin Calcium	471	130
Lisinopril	Lisinopril	471	123
Levothyroxine Sodium	Levothyroxine Sodium	350	96
Metformin Hcl	Metformin Hcl	330	94
Losartan Potassium	Losartan Potassium	313	88
Amlodipine Besylate	Amlodipine Besylate	301	83
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	274	38
Chlorthalidone	Chlorthalidone	233	63
Gabapentin	Gabapentin	219	63
Allopurinol	Allopurinol	199	54
Tamsulosin Hcl	Tamsulosin Hcl	185	54
Omeprazole	Omeprazole	160	49
Pantoprazole Sodium	Pantoprazole Sodium	141	34
Finasteride	Finasteride	140	42
Citalopram Hbr	Citalopram Hydrobromide	139	34
Ozempic	Semaglutide	126	23
Atenolol	Atenolol	111	23
Zolpidem Tartrate	Zolpidem Tartrate	108	17
Hydrochlorothiazide	Hydrochlorothiazide	106	29
Carvedilol	Carvedilol	101	30
Metoprolol Succinate	Metoprolol Succinate	98	30
Jardiance	Empagliflozin	94	27
Naproxen	Naproxen	94	33
Furosemide	Furosemide	87	33
Potassium Chloride	Potassium Chloride	87	28
Metoprolol Tartrate	Metoprolol Tartrate	86	26
Alendronate Sodium	Alendronate Sodium	81	17
Lovastatin	Lovastatin	81	23
Albuterol Sulfate Hfa	Albuterol Sulfate	69	25
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	66	15
Eliquis	Apixaban	62	21
Simvastatin	Simvastatin	62	20
Alprazolam	Alprazolam	61	11
Lorazepam	Lorazepam	60	17
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	60	15
Fluticasone Propionate	Fluticasone Propionate	56	21
Pregabalin	Pregabalin	55	18
Clonazepam	Clonazepam	54	suppressed
Farxiga	Dapagliflozin Propanediol	50	13
Prednisone	Prednisone	48	21
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	46	suppressed
Baclofen	Baclofen	44	suppressed
Celecoxib	Celecoxib	44	12
Azithromycin	Azithromycin	43	39
Amitriptyline Hcl	Amitriptyline Hcl	41	suppressed
Ibuprofen	Ibuprofen	41	13
Nifedipine Er	Nifedipine	40	17
Fentanyl	Fentanyl	37	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	37	12
Trazodone Hcl	Trazodone Hcl	36	11
Clopidogrel	Clopidogrel Bisulfate	35	12
Pravastatin Sodium	Pravastatin Sodium	35	suppressed
Ventolin Hfa	Albuterol Sulfate	35	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	33	suppressed
Fenofibrate	Fenofibrate	32	suppressed
Icosapent Ethyl	Icosapent Ethyl	32	suppressed
Cephalexin	Cephalexin	31	17
Duloxetine Hcl	Duloxetine Hcl	31	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	31	suppressed
Hydralazine Hcl	Hydralazine Hcl	30	suppressed
Benazepril Hcl	Benazepril Hcl	29	suppressed
Rybelsus	Semaglutide	29	suppressed
Tramadol Hcl	Tramadol Hcl	29	suppressed
Dutasteride	Dutasteride	26	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	26	21
Triamcinolone Acetonide	Triamcinolone Acetonide	26	16
Ezetimibe	Ezetimibe	25	suppressed
Glimepiride	Glimepiride	25	suppressed
Xarelto	Rivaroxaban	25	suppressed
Meclizine Hcl	Meclizine Hcl	24	suppressed
Morphine Sulfate Er	Morphine Sulfate	24	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	24	suppressed
Linzess	Linaclotide	23	suppressed
Ropinirole Hcl	Ropinirole Hcl	23	suppressed
Terazosin Hcl	Terazosin Hcl	23	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	22	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	22	suppressed
Montelukast Sodium	Montelukast Sodium	22	suppressed
Levofloxacin	Levofloxacin	20	16
Terbinafine Hcl	Terbinafine Hcl	20	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	20	suppressed
Amoxicillin	Amoxicillin	19	14
Sertraline Hcl	Sertraline Hcl	19	suppressed
Enalapril Maleate	Enalapril Maleate	18	suppressed
Famotidine	Famotidine	18	suppressed
Januvia	Sitagliptin Phosphate	18	suppressed
Leflunomide	Leflunomide	18	suppressed
Warfarin Sodium	Warfarin Sodium	18	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	17	suppressed
Humalog Kwikpen U-100	Insulin Lispro	16	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	16	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	16	suppressed
Oxycodone Hcl	Oxycodone Hcl	16	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	16	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	16	suppressed
Glipizide	Glipizide	15	suppressed
Mirtazapine	Mirtazapine	15	suppressed
Mounjaro	Tirzepatide	15	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	15	11
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Qvar Redihaler	Beclomethasone Dipropionate	15	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	15	suppressed
Valsartan	Valsartan	15	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Promethazine-Dm	Promethazine/Dextromethorphan	14	12
Propranolol Hcl Er	Propranolol Hcl	14	suppressed
Spironolactone	Spironolactone	14	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	13	suppressed
Levetiracetam	Levetiracetam	13	suppressed
Tresiba Flextouch U-100	Insulin Degludec	13	suppressed
Butalb-Acetaminoph-Caff-Codein	Butalbit/Acetamin/Caff/Codeine	12	suppressed
Bydureon Bcise	Exenatide Microspheres	12	suppressed
Meloxicam	Meloxicam	12	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	12	suppressed
Tresiba Flextouch U-200	Insulin Degludec	12	suppressed
Dexlansoprazole Dr	Dexlansoprazole	11	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	11	suppressed
Donepezil Hcl	Donepezil Hcl	11	suppressed
Estradiol	Estradiol	11	suppressed
Metformin Hcl Er	Metformin Hcl	11	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	11	suppressed
Mupirocin	Mupirocin	11	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	11	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error